← Back to headlines
U.S. FDA Grants Orphan Drug Designation to Gamgertamig
The U.S. FDA has granted Orphan Drug Designation to Gamgertamig for its use in treating Pemphigus.
24 Aug, 20:01 — 24 Aug, 20:01
Sources
Showing 1 of 1 sources
The U.S. FDA has granted Orphan Drug Designation to Gamgertamig for its use in treating Pemphigus.
